A method for simultaneous determination of antiviral drugs in pharmaceutical dosage forms has been developed and optimized using a Box-Behnken design-assisted RP-HPLC approach. The specifics of the method, including the number of antiviral drugs it can determine, are unclear as reports vary. The development of this method is part of a broader trend of optimizing analytical techniques, including RP-HPLC, for various pharmaceutical applications.